Neurodevelopmental Outcomes of Very-Low-Birth-Weight Infants without Severe Brain Lesions and Impact of Postnatal Steroid Use: A Single-Center Korean Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We used the Bayley Scales of Infant and Toddler Development (BSID)-III to analyze the incidence and risk factors of developmental delay in very-low-birth-weight infants without severe brain lesions. We further examined the correlation between the cumulative dexamethasone dose and developmental assessment results. Methods: We retrospectively analyzed data of preterm infants (birth weight <1,500 g) admitted to our neonatal intensive care unit between January 2014 to December 2020. The BSID-III scores obtained between the corrected ages of 12 and 24 months and after 24 months were analyzed. Developmental delay was defined as a composite score of <85 for the cognition, language, and motor domains. Univariate and multivariate analyses of developmental delay risk factors and developmental changes from the first to second BSID-III were performed. Correlations between the accumulated dexamethasone dose used for bronchopulmonary dysplasia (BPD) and the first and second test scores were analyzed. Results: Seventy-one and thirty-six infants completed the first and second tests, respectively. In both tests, developmental delay was most commonly observed in the language domain (26.8%, 47.2%). In multivariate analysis, mild BPD was identified as a developmental delay risk factor (P<0.05), whereas prenatal steroid use reduced the developmental delay risk (P<0.05). All domain scores were lower in the second test than in the first test. The cognition and language domain scores in the second test decreased with increasing cumulative dexamethasone doses. Conclusion: Very-low-birth-weight infants typically experience language delay, which can persist as they age.
Abstract
Purpose: We used the Bayley Scales of Infant and Toddler Development (BSID)-III to analyze the incidence and risk factors of developmental delay in very-low-birth-weight infants without severe brain lesions. We further examined the correlation between the cumulative dexamethasone dose and developmental assessment results. Methods: We retrospectively analyzed data of preterm infants (birth weight <1,500 g) admitted to our neonatal intensive care unit between January 2014 to December 2020. The BSID-III scores obtained between the corrected ages of 12 and 24 months and after 24 months were analyzed. Developmental delay was defined as a composite score of <85 for the cognition, language, and motor domains. Univariate and multivariate analyses of developmental delay risk factors and developmental changes from the first to second BSID-III were performed. Correlations between the accumulated dexamethasone dose used for bronchopulmonary dysplasia (BPD) and the first and second test scores were analyzed. Results: Seventy-one and thirty-six infants completed the first and second tests, respectively. In both tests, developmental delay was most commonly observed in the language domain (26.8%, 47.2%). In multivariate analysis, mild BPD was identified as a developmental delay risk factor (P<0.05), whereas prenatal steroid use reduced the developmental delay risk (P<0.05). All domain scores were lower in the second test than in the first test. The cognition and language domain scores in the second test decreased with increasing cumulative dexamethasone doses. Conclusion: Very-low-birth-weight infants typically experience language delay, which can persist as they age.
참고문헌 (37)
- 김진규, "Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23-26 Weeks Gestation", Journal of Korean Medical Science, 31(3), pp.423~429 (2016), 대한의학회
- Stoll BJ, "Trends in care practices, morbidity, and mortality of ex tremely preterm neonates, 1993-2012", JAMA, 314, pp.1039~1051 (2015)
- Woodward LJ, "Neonatal MRI to predict neurodevelopmental outcomes in preterm infants", N Engl J Med, 355, pp.685~694 (2006)
- Jeng SF, "Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants", Dev Med Child Neurol, 50, pp.51~57 (2008)
- Grier DG, "Corticosteroids in the prevention and management of bronchopulmonary dysplasia", Semin Neonatol, 8, pp.83~91 (2003)
- Sharp M, "Counterbalanced comparison of the BSID-II and Bayley-III at eighteen to twenty-two months corrected age", J Dev Behav Pediatr, 38, pp.322~329 (2017)
- Johnson S, "Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used?", Pediatr Res, 75, pp.670~674 (2014)
- Ehrenkranz RA, "Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants", Pediatrics, 117, pp.1253~1261 (2006)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
- 안성호, "Assessment of Preterm Infants Using the Bayley-III Scales in Korea", Annals of Rehabilitation Medicine, 41(5), pp.843~850 (2017), 대한재활의학회
- Guerra CC, "Premature infants with birth weights of 1500-1999g exhibit considerable delays in several developmental areas", Acta Paediatr, 103, pp.e1~e6 (2014)
- 장윤실, "한국 신생아 네트워크(Korean Neonatal Network, KNN)의 설립", Neonatal medicine, 20(2), pp.169~178 (2013), 대한신생아학회
- 2016Korean Neonatal Network Annual Report, "The Executive Committee of Korean Neonatal Network", Korean Centers for Disease Control and Prevention, 4~63 (2017)
- 2020Korean Neonatal Network Annual Report, "The Executive Committee of Korean Neonatal Network", Korean Centers for Disease Control and Prevention, 4~68 (2021)
- 2017Korean Neonatal Network Annual Report, "The Executive Committee of Korean Neonatal Network", Korean Centers for Disease Control and Prevention, 4~65 (2018)
- 2018Korean Neonatal Network Annual Report, "The Executive Committee of Korean Neonatal Network", Korean Centers for Disease Control and Prevention, 4~68 (2021)
- 2019Korean Neonatal Network Annual Report, "The Executive Committee of Korean Neonatal Network", Korean Centers for Disease Control and Prevention, 4~68 (2021)
- Jong Ho Cha, "Developmental Outcome of Very-Low-Birth-Weight Infants without Major Brain Injuries Based on Data from the Korean Neonatal Network: A Nationwide Cohort Study", Neonatal medicine, 27(4), pp.151~158 (2020), 대한신생아학회[DOI]
- Sansavini A, "Does preterm birth increase a child's risk for language impairment?", Early Hum Dev, 86, pp.765~772 (2010)
- Kiechl-Kohlendorfer U, "Adverse neurodevelopmental outcome in preterm infants : risk factor profiles for different gestational ages", Acta Paediatr, 98, pp.792~796 (2009)
- Kerstjens JM, "Neonatal morbidities and developmental delay in moderately preterm-born children", Pediatrics, 130, pp.e265~e272 (2012)
- Twilhaar ES, "Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors : a meta-analysis and meta-regression", JAMA Pediatr, 172, pp.361~367 (2018)
- Gentle SJ, "Association of antenatal corticosteroids and magnesium sulfate therapy with neurodevelopmental outcome in extremely preterm children", Obstet Gynecol, 135, pp.1377~1386 (2020)
- Srinivas Jois R, "Neurodevelopmental outcome of late-preterm infants : a pragmatic review", Aust J Gen Pract, 47, pp.776~781 (2018)
- Malavolti AM, "Bronchopulmonary dysplasia-impact of severity and timing of diagnosis on neurodevelopment of preterm infants : a retrospective cohort study", BMJ Paediatr Open, 2, pp.e000165~ (2018)
- Wood NS, "The EPICure study : associations and antecedents of neurological and developmental disability at 30months of age following extremely preterm birth", Arch Dis Child Fetal Neonatal Ed, 90, pp.F134~F140 (2005)
- Wilson-Costello D, "Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age : effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants", Pediatrics, 123, pp.e430~e437 (2009)
- Davidovitch M, "Postnatal steroid therapy is associated with autism spectrum disorder in children and adolescents of very low birth weight infants", Pediatr Res, 87, pp.1045~1051 (2020)
- Doyle LW, "An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants : effect modification by risk of bronchopulmonary dysplasia", J Pediatr, 165, pp.1258~1260 (2014)
- Doyle LW, "Late(>7 days)systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants", Cochrane Database Syst Rev, 10, pp.CD001145~ (2017)
- Wood NS, "Neurologic and developmental disability after extremely preterm birth. EPICure Study Group", N Engl J Med, 343, pp.378~384 (2000)
- Maalouf EF, "Magnetic resonance imaging of the brain in a cohort of extremely preterm infants", J Pediatr, 135, pp.351~357 (1999)
- Volpe JJ, "Cerebral white matter injury of the premature infantmore common than you think", Pediatrics, 112(1 Pt 1), pp.176~180 (2003)
- de Bruine FT, "Clinical implications of MR imaging findings in the white matter in very preterm infants : a 2-year follow-up study", Radiology, 261, pp.899~906 (2011)
- Brostrom L, "Clinical implications of diffuse excessive high signal intensity(DEHSI)on neonatal MRI in school age children born extremely preterm", PLoS One, 11, pp.e0149578~ (2016)
- Murner-Lavanchy IM, "Thirteen-year outcomes in very preterm children associated with diffuse excessive high signal intensity on neonatal magnetic resonance imaging", J Pediatr, 206, pp.66~71 (2019)
- Rath CP, "Diffuse excessive high signal intensity on term equivalent MRI does not predict disability : a systematic review and meta-analysis", Arch Dis Child Fetal Neonatal Ed, 106, pp.9~16 (2021)